BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19306058)

  • 1. Aquaporin 1 (AQP1) expression is a novel characteristic feature of a particularly aggressive subgroup of basal-like breast carcinomas.
    Otterbach F; Callies R; Adamzik M; Kimmig R; Siffert W; Schmid KW; Bankfalvi A
    Breast Cancer Res Treat; 2010 Feb; 120(1):67-76. PubMed ID: 19306058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Aquaporin 1 expression in invasive breast carcinomas].
    Otterbach F; Callies R; Kimmig R; Schmid KW; Bánkfalvi A
    Pathologe; 2008 Nov; 29 Suppl 2():357-62. PubMed ID: 18841368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of aquaporin 1 in primary renal tumors: a prognostic indicator for clear-cell renal cell carcinoma.
    Huang Y; Murakami T; Sano F; Kondo K; Nakaigawa N; Kishida T; Kubota Y; Nagashima Y; Yao M
    Eur Urol; 2009 Oct; 56(4):690-8. PubMed ID: 18930582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneous expression of the aquaporin 1 (AQP1) water channel in tumors of the prostate, breast, ovary, colon and lung: a study using high density multiple human tumor tissue microarrays.
    Mobasheri A; Airley R; Hewitt SM; Marples D
    Int J Oncol; 2005 May; 26(5):1149-58. PubMed ID: 15809704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.
    Rakha EA; Putti TC; Abd El-Rehim DM; Paish C; Green AR; Powe DG; Lee AH; Robertson JF; Ellis IO
    J Pathol; 2006 Mar; 208(4):495-506. PubMed ID: 16429394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of aquaporin-1 water channel protein expression with tumor angiogenesis in human astrocytoma.
    El Hindy N; Bankfalvi A; Herring A; Adamzik M; Lambertz N; Zhu Y; Siffert W; Sure U; Sandalcioglu IE
    Anticancer Res; 2013 Feb; 33(2):609-13. PubMed ID: 23393355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of osteopontin in patients with triple-negative breast cancer.
    Wang X; Chao L; Ma G; Chen L; Tian B; Zang Y; Sun J
    Eur J Clin Invest; 2008 Jun; 38(6):438-46. PubMed ID: 18452545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
    Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and prognostic significance of metalloproteases and their inhibitors in luminal A and basal-like phenotypes of breast carcinoma.
    González LO; Corte MD; Junquera S; González-Fernández R; del Casar JM; García C; Andicoechea A; Vázquez J; Pérez-Fernández R; Vizoso FJ
    Hum Pathol; 2009 Sep; 40(9):1224-33. PubMed ID: 19439346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of breast cancer tissue microarrays shows high cox-2 expression is associated with poor outcome.
    Zerkowski MP; Camp RL; Burtness BA; Rimm DL; Chung GG
    Cancer Invest; 2007 Feb; 25(1):19-26. PubMed ID: 17364553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-inducible factor 1alpha is closely linked to an aggressive phenotype in breast cancer.
    Yamamoto Y; Ibusuki M; Okumura Y; Kawasoe T; Kai K; Iyama K; Iwase H
    Breast Cancer Res Treat; 2008 Aug; 110(3):465-75. PubMed ID: 17805961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breast.
    Kleer CG; Griffith KA; Sabel MS; Gallagher G; van Golen KL; Wu ZF; Merajver SD
    Breast Cancer Res Treat; 2005 Sep; 93(2):101-10. PubMed ID: 16187229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tie2/Tek expression in breast carcinoma: correlations of immunohistochemical assays and long-term follow-up in a series of 909 patients.
    Dales JP; Garcia S; Bonnier P; Duffaud F; Meunier-Carpentier S; Andrac-Meyer L; Lavaut MN; Allasia C; Charpin C
    Int J Oncol; 2003 Feb; 22(2):391-7. PubMed ID: 12527939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
    Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of luminal and basal cytokeratins in human breast carcinoma.
    Abd El-Rehim DM; Pinder SE; Paish CE; Bell J; Blamey RW; Robertson JF; Nicholson RI; Ellis IO
    J Pathol; 2004 Jun; 203(2):661-71. PubMed ID: 15141381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of P-cadherin expression to basal phenotype of breast carcinoma.
    Potemski P; Kusińska R; Kubiak R; Piekarski JH; Płuciennik E; Bednarek AK; Kordek R
    Pol J Pathol; 2007; 58(3):183-8. PubMed ID: 18074863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast carcinomas expressing basal markers have poor clinical outcome regardless of estrogen receptor status.
    Shin BK; Lee Y; Lee JB; Kim HK; Lee JB; Cho SJ; Kim A
    Oncol Rep; 2008 Mar; 19(3):617-25. PubMed ID: 18288392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study.
    Salvucci O; Bouchard A; Baccarelli A; Deschênes J; Sauter G; Simon R; Bianchi R; Basik M
    Breast Cancer Res Treat; 2006 Jun; 97(3):275-83. PubMed ID: 16344916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basal-HER2 phenotype shows poorer survival than basal-like phenotype in hormone receptor-negative invasive breast cancers.
    Liu H; Fan Q; Zhang Z; Li X; Yu H; Meng F
    Hum Pathol; 2008 Feb; 39(2):167-74. PubMed ID: 18045647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of cytokeratin 5/6 in invasive lobular carcinoma of the breast: evidence of a basal-like subset?
    Fadare O; Wang SA; Hileeto D
    Hum Pathol; 2008 Mar; 39(3):331-6. PubMed ID: 18261623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.